These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 28127812)
1. The Impact of Transforming Growth Factor-β Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T J Cardiovasc Electrophysiol; 2017 Apr; 28(4):402-409. PubMed ID: 28127812 [TBL] [Abstract][Full Text] [Related]
2. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A Europace; 2015 Dec; 17(12):1807-15. PubMed ID: 25995388 [TBL] [Abstract][Full Text] [Related]
3. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy. Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936 [TBL] [Abstract][Full Text] [Related]
4. Role of serum TGF-β1 level in atrial fibrosis and outcome after catheter ablation for paroxysmal atrial fibrillation. Tian Y; Wang Y; Chen W; Yin Y; Qin M Medicine (Baltimore); 2017 Dec; 96(51):e9210. PubMed ID: 29390467 [TBL] [Abstract][Full Text] [Related]
5. Impact of Voltage Mapping to Guide Whether to Perform Ablation of the Posterior Wall in Patients With Persistent Atrial Fibrillation. Cutler MJ; Johnson J; Abozguia K; Rowan S; Lewis W; Costantini O; Natale A; Ziv O J Cardiovasc Electrophysiol; 2016 Jan; 27(1):13-21. PubMed ID: 26515166 [TBL] [Abstract][Full Text] [Related]
6. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation. Wu CH; Hu YF; Chou CY; Lin YJ; Chang SL; Lo LW; Tuan TC; Li CH; Chao TF; Chung FP; Liao JN; Chen SA Heart Rhythm; 2013 Jan; 10(1):10-5. PubMed ID: 22982967 [TBL] [Abstract][Full Text] [Related]
8. Low P-wave amplitude (<0.1 mV) in lead I is associated with displaced inter-atrial conduction and clinical recurrence of paroxysmal atrial fibrillation after radiofrequency catheter ablation. Park JK; Park J; Uhm JS; Joung B; Lee MH; Pak HN Europace; 2016 Mar; 18(3):384-91. PubMed ID: 25969437 [TBL] [Abstract][Full Text] [Related]
9. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation. Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of Focal Atrial Tachycardia During the Ablation Procedure Is Associated With Arrhythmia Recurrence After Termination of Persistent Atrial Fibrillation. Iwai S; Takahashi Y; Masumura M; Yamashita S; Doi J; Yamamoto T; Sakakibara A; Nomoto H; Yoshida Y; Sugiyama T; Oumi T; Ohno M; Sato Y; Hirao K; Isobe M J Cardiovasc Electrophysiol; 2017 May; 28(5):489-497. PubMed ID: 28188960 [TBL] [Abstract][Full Text] [Related]
11. Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome. Richter B; Gwechenberger M; Socas A; Zorn G; Albinni S; Marx M; Wolf F; Bergler-Klein J; Loewe C; Bieglmayer C; Binder T; Wojta J; Gössinger HD Int J Cardiol; 2011 Oct; 152(2):231-6. PubMed ID: 20692054 [TBL] [Abstract][Full Text] [Related]
12. Coefficient of Variation of P-Wave Duration Is a Novel Atrial Heterogeneity Index to Predict Recurrence of Atrial Fibrillation After Catheter Ablation. Nakatani Y; Sakamoto T; Mizumaki K; Nishida K; Kataoka N; Tsujino Y; Yamaguchi Y; Inoue H J Cardiovasc Electrophysiol; 2016 May; 27(5):542-8. PubMed ID: 26756553 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy. Chang HY; Lo LW; Lin YJ; Chang SL; Hu YF; Li CH; Chao TF; Chung FP; Ha TL; Singhal R; Chong E; Yin WH; Tsao HM; Hsieh MH; Chen SA J Cardiovasc Electrophysiol; 2013 Mar; 24(3):250-8. PubMed ID: 23210627 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting. Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608 [TBL] [Abstract][Full Text] [Related]